cytarabine has been researched along with chloroquine in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (23.53) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (17.65) | 29.6817 |
| 2010's | 8 (47.06) | 24.3611 |
| 2020's | 2 (11.76) | 2.80 |
| Authors | Studies |
|---|---|
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Brown, M; Rosenthal, LJ | 1 |
| Girard, M; Manteuil, S | 1 |
| Ota, K | 1 |
| Katz, C; Melchionne, S; Sivak, A; Van Duuren, BL | 1 |
| Ravet, O | 1 |
| Barbosa, CM; Bincoletto, C; Jurkiewicz, A; Palmeira dos Santos, C; Pereira, GJ; Smaili, SS | 1 |
| Ajami, M; Anjam-Najmedini, A; Atashi, A; Houshmand, M; Kazemi, A; Ojaghi, M; Sadri, M; Tavakoli, R; Yazdi, N; Zarif, MN | 1 |
| Bremer, E; Huls, G; Lourens, HJ; Visser, N; Wiersma, VR | 1 |
| Feng, B; Fu, JF; Kan, WJ; Li, J; Li, JN; Liu, MM; Luo, GH; Song, N; Tu, YT; Wang, HL; Wei, G; Wu, WB; Xu, GY; Xu, R; Zhou, YB | 1 |
3 review(s) available for cytarabine and chloroquine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Multiple combination therapy in cancer chemotherapy in Japan.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Chloroquine; Cyclophosphamide; Cytarabine; Drug Synergism; Fluorouracil; Humans; Japan; Leukemia; Lymphoma; Mercaptopurine; Mitomycins; Neoplasms; Podophyllin; Prednisolone; Thiotepa; Vincristine; Vitamin K 1 | 1969 |
[Toxic effects of medications on the cornea].
Topics: Belgium; Chloroquine; Cornea; Corneal Diseases; Cytarabine; Drug-Related Side Effects and Adverse Reactions; Humans; Isotretinoin; Keratitis; Pharmaceutical Preparations; Rifabutin; Tamoxifen | 2007 |
14 other study(ies) available for cytarabine and chloroquine
| Article | Year |
|---|---|
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
The control of SV40 transcription during a lytic infection: late RNA synthesis in the presence of inhibitors of DNA replication.
Topics: Cell Line; Chloroquine; Cytarabine; DNA Replication; DNA, Viral; Floxuridine; Kidney; Mutation; Nucleic Acid Hybridization; RNA, Viral; Simian virus 40; Transcription, Genetic | 1977 |
Inhibitors of DNA synthesis: their influence on replication and transcription of simian virus 40 DNA.
Topics: Animals; Cell Line; Centrifugation, Zonal; Chloroquine; Cytarabine; DNA Replication; Floxuridine; Haplorhini; Hydroxyurea; In Vitro Techniques; Kidney; Lucanthone; Mutation; Nucleic Acid Hybridization; Simian virus 40; Temperature; Thymidine; Time Factors; Transcription, Genetic; Tritium; Virus Replication | 1974 |
Inhibition of tumor induction in two-stage carcinogenesis on mouse skin.
Topics: Aflatoxins; Animals; Antineoplastic Agents; Benz(a)Anthracenes; Chloroquine; Cyclohexanes; Cytarabine; Dactinomycin; Ethers, Cyclic; Female; Mice; Neoplasms, Experimental; Skin Neoplasms; Uracil | 1969 |
Comparative study of autophagy inhibition by 3MA and CQ on Cytarabine‑induced death of leukaemia cells.
Topics: Adenine; Antimalarials; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Autophagy; Blotting, Western; Caspase 3; Cell Proliferation; Chloroquine; Cytarabine; Flow Cytometry; Fluorescent Antibody Technique; Humans; Immunophenotyping; Leukemia; Receptors, Retinoic Acid; Retinoic Acid Receptor alpha; Tumor Cells, Cultured; Tumor Stem Cell Assay | 2014 |
The anticancer effects of pharmacological inhibition of autophagy in acute erythroid leukemia cells.
Topics: Adenine; Antimetabolites, Antineoplastic; Autophagy; Cell Line, Tumor; Chloroquine; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinase Inhibitor p27; Cytarabine; Down-Regulation; G1 Phase; Humans; Leukemia, Erythroblastic, Acute; MicroRNAs; Resting Phase, Cell Cycle; Up-Regulation | 2018 |
Inhibition of Autophagy Does Not Re-Sensitize Acute Myeloid Leukemia Cells Resistant to Cytarabine.
Topics: Antimetabolites, Antineoplastic; Autophagy; Cell Line, Tumor; Chloroquine; Cytarabine; Drug Resistance, Neoplasm; Humans; Leukemia, Myeloid, Acute; Tumor Cells, Cultured | 2021 |
Chloroquine enhances the efficacy of chemotherapy drugs against acute myeloid leukemia by inactivating the autophagy pathway.
Topics: Antineoplastic Combined Chemotherapy Protocols; Autophagy; Chloroquine; Cytarabine; Daunorubicin; Humans; Idarubicin; Leukemia, Myeloid, Acute | 2023 |